Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
Pivonello et al • 2021 • Front. Endocrinol., 14 July 2021
Pivonello et al • 2021 • Front. Endocrinol., 14 July 2021
Pivonello et al. • 2019 • American Association of Clinical Endocrinologists (AACE) 28th Annual Scientific & Clinical Congress
Elhassan et al • 2019 • Ann Intern Med.
Yuen et al. • 2017 • J Endocr Soc. 2017;1(4):237-246.
Editorial Team • 2017 • Diabetes
Moraitis AG, Auchus RJ. • 2016 • Case Rep Endocrinol. 2016;2016:8453801.
Steffensen et al • 2016 • European Journal of Endocrinology
Costa et al • 2016 • J Diabetes Complications.
Yuen et al. • 2015 • Endocr Pract. 2015;21(10):1087-92.
Kennedy L. • 2015 • Endocr Pract. 2015;21(10):1175-7.